At the end of 2006, drug-eluting stents were placed on the balance billing list. Although that lessened the financial burden, patients were still unclear about how they differed from traditional stents.
2006 年底，塗藥血管支架納入差額負擔項目，民眾雖然負擔減輕不少，但仍不明白其間的差異。